private:ascentagepharma
|
12898756
|
Nov 18th, 2019 12:00AM
|
Ascentage Pharma
|
668
|
74.00
|
Open
|
Biotechnology
|
Nov 18th, 2019 03:45PM
|
Nov 18th, 2019 03:45PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 16th, 2019 12:00AM
|
Ascentage Pharma
|
665
|
74.00
|
Open
|
Biotechnology
|
Nov 16th, 2019 03:56PM
|
Nov 16th, 2019 03:56PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 15th, 2019 12:00AM
|
Ascentage Pharma
|
665
|
74.00
|
Open
|
Biotechnology
|
Nov 15th, 2019 12:38PM
|
Nov 15th, 2019 12:38PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 14th, 2019 12:00AM
|
Ascentage Pharma
|
665
|
74.00
|
Open
|
Biotechnology
|
Nov 14th, 2019 05:54PM
|
Nov 14th, 2019 05:54PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 13th, 2019 12:00AM
|
Ascentage Pharma
|
665
|
74.00
|
Open
|
Biotechnology
|
Nov 13th, 2019 01:06PM
|
Nov 13th, 2019 01:06PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 12th, 2019 12:00AM
|
Ascentage Pharma
|
663
|
74.00
|
Open
|
Biotechnology
|
Nov 12th, 2019 02:48PM
|
Nov 12th, 2019 02:48PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 11th, 2019 12:00AM
|
Ascentage Pharma
|
661
|
73.00
|
Open
|
Biotechnology
|
Nov 11th, 2019 02:46PM
|
Nov 11th, 2019 02:46PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 10th, 2019 12:00AM
|
Ascentage Pharma
|
658
|
73.00
|
Open
|
Biotechnology
|
Nov 10th, 2019 05:52PM
|
Nov 10th, 2019 05:52PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 9th, 2019 12:00AM
|
Ascentage Pharma
|
656
|
73.00
|
Open
|
Biotechnology
|
Nov 9th, 2019 05:20PM
|
Nov 9th, 2019 05:20PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|
private:ascentagepharma
|
12898756
|
Nov 8th, 2019 12:00AM
|
Ascentage Pharma
|
656
|
73.00
|
Open
|
Biotechnology
|
Nov 8th, 2019 02:30PM
|
Nov 8th, 2019 02:30PM
|
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company’s expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
|
Open
|
|
Open
|
800 King Farm Blvd, suite 300
|
Rockville
|
Maryland
|
US
|
20850
|
|
Ascentage Pharma
|
Health Care
|
Health Care Equipment & Services
|